{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:19:47Z","timestamp":1786990787137,"version":"build-2736575974"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007338","name":"All-India Institute of Medical Sciences","doi-asserted-by":"publisher","award":["F.5-59\/IRG\/2010\/RS"],"award-info":[{"award-number":["F.5-59\/IRG\/2010\/RS"]}],"id":[{"id":"10.13039\/501100007338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ijmmb.2025.100793","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T10:54:47Z","timestamp":1738320887000},"page":"100793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["In-vitro susceptibility of cefiderocol and other comparators in carbapenem-resistant Gram-negative bacilli: A study from India"],"prefix":"10.1016","volume":"54","author":[{"given":"Akansha","family":"Didwania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8311-4112","authenticated-orcid":false,"given":"Sarita","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9942-9338","authenticated-orcid":false,"given":"Deepak","family":"Kocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9666-5434","authenticated-orcid":false,"given":"Hitender","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9229-1081","authenticated-orcid":false,"given":"Arvind","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8619-7929","authenticated-orcid":false,"given":"Manish","family":"Soneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naval K.","family":"Vikram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8797-5286","authenticated-orcid":false,"given":"Seema","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9794-781X","authenticated-orcid":false,"given":"Benu","family":"Dhawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimal Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7381-1504","authenticated-orcid":false,"given":"Rama","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoranjan","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6603-601X","authenticated-orcid":false,"given":"Naveet","family":"Wig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7834-2754","authenticated-orcid":false,"given":"Arti","family":"Kapil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmmb.2025.100793_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40121-020-00286-6","article-title":"Cefiderocol: a novel agent for the management of multidrug-resistant gram-negative organisms","volume":"9","author":"Wu","year":"2020","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.ijmmb.2025.100793_bib5","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2022"},{"key":"10.1016\/j.ijmmb.2025.100793_bib6","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1128\/AAC.05108-11","article-title":"A novel variant, NDM-5, of the New Delhi metallo-\u03b2-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom","volume":"55","author":"Hornsey","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijmmb.2025.100793_bib7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/jac\/dkp498","article-title":"Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae","volume":"65","author":"Dallenne","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijmmb.2025.100793_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1473-3099(20)30796-9","article-title":"Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial","volume":"21","author":"Bassetti","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijmmb.2025.100793_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1473-3099(20)30731-3","article-title":"Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial","volume":"21","author":"Wunderink","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijmmb.2025.100793_bib10","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S1473-3099(18)30554-1","article-title":"Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial","volume":"18","author":"Portsmouth","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijmmb.2025.100793_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.37201\/req\/s01.12.2021","article-title":"Cefiderocol, a new antibiotic against multidrug-resistant Gram-negative bacteria","volume":"34","author":"Silva","year":"2021","journal-title":"Rev Espa\u00f1ola Quimioter"},{"key":"10.1016\/j.ijmmb.2025.100793_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01990-21","article-title":"In vitro susceptibility of gram-negative pathogens to cefiderocol in five consecutive annual multinational SIDERO-WT surveillance studies, 2014 to 2019","volume":"66","author":"Karlowsky","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijmmb.2025.100793_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02712-21","article-title":"In vitro activity of cefiderocol against U.S. And European gram-negative clinical isolates collected in 2020 as part of the SENTRY antimicrobial surveillance program","volume":"10","author":"Shortridge","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijmmb.2025.100793_bib14","doi-asserted-by":"crossref","first-page":"447.e1","DOI":"10.1016\/j.cmi.2021.07.018","article-title":"In vitro activity of the novel siderophore cephalosporin, cefiderocol, in Gram-negative pathogens in Europe by site of infection","volume":"28","author":"Candel","year":"2022","journal-title":"Clin Microbiol Infection"},{"key":"10.1016\/j.ijmmb.2025.100793_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00966-20","article-title":"Comparison of agar dilution to broth microdilution for testing in vitro activity of cefiderocol against gram-negative bacilli","volume":"59","author":"Albano","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijmmb.2025.100793_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01582-20","article-title":"In vitro activity of cefiderocol, a siderophore cephalosporin, against multidrug-resistant gram-negative bacteria","volume":"64","author":"Mushtaq","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijmmb.2025.100793_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01649-20","article-title":"Cefiderocol antimicrobial susceptibility testing against multidrug-resistant gram-negative bacilli: a comparison of disk diffusion to broth microdilution","volume":"59","author":"Morris","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijmmb.2025.100793_bib18","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3390\/antibiotics11101352","article-title":"In vitro activity of cefiderocol and comparators against carbapenem-resistant gram-negative pathogens from France and Belgium","volume":"11","author":"Oueslati","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijmmb.2025.100793_bib19","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.2147\/IDR.S378579","article-title":"Analysis of in vitro activity of cefiderocol against carbapenem-resistant gram-negative bacilli by broth microdilution and disk diffusion method: a single-center study in odisha, India","volume":"15","author":"Nayak","year":"2022","journal-title":"Infect Drug Resist"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085725000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085725000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T20:32:18Z","timestamp":1747427538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085725000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":16,"alternative-id":["S0255085725000064"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmmb.2025.100793","relation":{},"ISSN":["0255-0857"],"issn-type":[{"value":"0255-0857","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-vitro susceptibility of cefiderocol and other comparators in carbapenem-resistant Gram-negative bacilli: A study from India","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmmb.2025.100793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100793"}}